Skip to content

美迈德生物

US · MDXG #3541 按市值排名
4.43 -0.25 -5.34%
实时 - 追踪5344个代码 - 心跳于17秒前 · 2026-10-16 19:30

✦ 量化股权信号 计算方式说明

增持
  • 最近一期(2026/Q3)披露持股的机构数量增加了3家。
  • 机构持股总比例上升了0.4个百分点。

机构持股

机构持股比例
77.85% +0.43pp
机构数量
262 +3
数据截至
2026/Q3 较上一报告期

持股变动 vs 资金流向

方向分歧

机构在上一报告期增持了股份,同时该股在最近20个交易日的主力资金呈净流出——两者方向出现分歧。

机构持股变动数据按季度发布且存在滞后;资金流向数据为每日更新。请将其作为方向性的交叉验证参考,而非精确的择时信号。

持股人类型

Mutual Fund38.18%
VC/PE Fund19.34%
Hedge Fund15.19%
Public Company2.45%
Individual/Insider1.91%
Private Company1.26%
Family Office/Trust0.54%
Government Pension Fund0.32%
Bank/Investment Bank0.28%
Other20.54%

主要股东 截至 2026-06-30

Essex Woodlands Management, Inc. 19.34% · 28.20M 股
BlackRock 8.34% · 12.15M 股
Trigran Investments, Inc. 4.92% · 7.17M 股
Vanguard Capital Management, LLC 4.09% · 5.96M 股
State Street Global Advisors 3.83% · 5.58M 股
Nantahala Capital Management, LLC 3.27% · 4.77M 股
Paradigm Capital Management, Inc. 2.79% · 4.07M 股
Geode Capital Management, LLC 2.16% · 3.14M 股
AQR Capital Management 1.68% · 2.45M 股
Renaissance Technologies Corp. 1.68% · 2.44M 股

条形长度是相对于此处列出的最大股东而言,并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 31次买入 · 19次卖出

姓名职务持股比例
Essex Woodlands Management, Inc. -- 19.34%
K. Newton Independent Director 0.28%
William Hulse General Counsel & Chief Administrative Officer 0.25%
Joseph Capper Chief Executive Officer 0.21%
Ricci Whitlow Former Chief Operating Officer 0.20%
Douglas Rice Chief Financial Officer 0.15%
James Bierman Independent Director 0.15%
William Hawkins Independent Preferred Director 0.14%
M. Behrens Wilsey Independent Chairperson 0.13%
Cato Laurencin Independent Director 0.11%

内部人交易 最近的 Form 4 申报记录

日期姓名职务类型股数价格
2026-07-01 Douglas Rice Chief Financial Officer Sale to Issuer -12,749 $3.95
2026-06-23 Kimberly Maersk-Moller Former Officer Sale to Issuer -19,820 $3.83
2026-06-09 James Bierman Independent Director Other Acquisition +50,913 $3.64
2026-06-09 William Hawkins Independent Preferred Director Other Acquisition +50,913 $3.64
2026-06-09 Dorothy Puhy Independent Director Other Acquisition +50,913 $3.64
2026-06-09 Tiffany Olson Independent Director Other Acquisition +50,913 $3.64
2026-06-09 K. Newton Independent Director Other Acquisition +50,913 $3.64
2026-03-12 William Hulse General Counsel & Chief Administrative Officer Sale to Issuer -20,245 $4.38
2026-03-12 Kimberly Maersk-Moller Former Officer Sale to Issuer -6,762 $4.38
2026-03-09 William Hulse General Counsel & Chief Administrative Officer Derivative Exercise and Sale -61,460 $4.50
2026-03-09 William Hulse General Counsel & Chief Administrative Officer Derivative Exercise and Retained +74,904 $4.50
2026-03-09 Douglas Rice Chief Financial Officer Derivative Exercise and Sale -96,363 $4.50
2026-03-09 Douglas Rice Chief Financial Officer Derivative Exercise and Retained +146,637 $4.50
2026-03-09 Kimberly Maersk-Moller Former Officer Derivative Exercise and Sale -21,270 $4.50
2026-03-09 Kimberly Maersk-Moller Former Officer Derivative Exercise and Retained +21,575 $4.50
2026-03-03 Joseph Capper Chief Executive Officer Other Acquisition +371,094 --
2026-03-03 Joseph Capper Chief Executive Officer Other Derivative Acquisition +310,574 $5.10
2026-03-03 William Hulse General Counsel & Chief Administrative Officer Other Acquisition +74,987 --
2026-03-03 William Hulse General Counsel & Chief Administrative Officer Other Derivative Acquisition +62,758 $5.10
2026-03-03 Douglas Rice Chief Financial Officer Other Acquisition +74,163 --

Form 4 申报记录,每家公司显示最新的一批。"Other Derivative Acquisition"(其他衍生品获取)类目多为限制性股票/期权归属,并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 19:30:04 · 仅供参考,不构成投资建议,也未考虑您的具体情况。

美迈德生物 讨论区 0 条评论

发表评论